相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy
Everett Stone et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma
Lars Stelter et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
Evan S. Glazer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Gastrosplenic Fistula From Hodgkin's Lymphoma
Carolyn D. Seib et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1 alpha/Sp4
Wen-Bin Tsai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Arginine deprivation as a targeted therapy for cancer
L. Feun et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Advances in the systemic therapy of malignant pleural mesothelioma
Dean A. Fennell et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
Peter W. Szlosarek et al.
CLINICAL CANCER RESEARCH (2006)
Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study
A Bottomley et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pegylated arginine deiminase treatment of patients with metastatic melanoma: Results from phase I and II studies
PA Ascierto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Medical progress - Advances in malignant mesothelioma
BWS Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies
F Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
